Clinical Trial Update: YOLT-204 in Patients With Hemoglobinopathies [EARLY_Phase 1]

View source ↗

Summary

This is an early Phase 1 clinical trial update for YOLT-204 in patients with hemoglobinopathies, including transfusion-dependent beta-thalassemia and sickle cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Sickle Cell Disease

Drugs mentioned

• YOLT-204

Snippet

Sponsor: Guangzhou Women and Children's Medical Center | Conditions: Hemoglobinopathies (Transfusion-dependent β-thalassemia and Sickle Cell Disease) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING